Used phony journals to push Vioxx
pharma giant Merck has been accused of using unscrupulous methods, including publication of fake journals, to promote its anti-arthritis drug Vioxx.
The evidence against Merck was presented before an Australian court in May after it began hearing a four-year-old lawsuit. Merck paid a well-known academic publisher, Elsevier, to compile favourable articles on Vioxx and Fosamax, an osteoporosis drug, and made them look like peer-reviewed publications; six publications were brought out between 2000 and 2005.
The fake journals were exposed when George Jelinek, a doctor in Perth, Australia, found they were just a collection of reprints from other Elsevier journals with reviews, news and commentary on Merck
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/merck-faked-promote-drug
[2] http://admin.indiaenvironmentportal.org.in/category/author/sumana-narayanan
[3] http://admin.indiaenvironmentportal.org.in/category/newspaper/down-earth
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-effects
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/physical-disability
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/information
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/science-journalism
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/australia
